Search Results
10
Everything
Search Filters
Tag
Cell Therapy
Cell Therapy Technologies Market Report, Growth Forecasts for 2025-2030 and Profiles of Danaher, Merck, Lonza, Sartorius, Promega, BD, Miltenyi Biotec, CellPort Software, Shimadzu and more
March 25, 2025 09:34 ET
|
Research and Markets
Dublin, March 25, 2025 (GLOBE NEWSWIRE) -- The "Cell Therapy Technologies Market Size, Share & Trends Analysis Report by Product (Raw Materials, Instruments), Workflow (Separation, Expansion),...
T-Cell Therapy Market Research 2025: Over 10 Approved Therapies and More than 1,200 Preclinical / Clinical Therapy Candidates - Global Industry Trends and Forecasts to 2035
March 25, 2025 06:46 ET
|
Research and Markets
Dublin, March 25, 2025 (GLOBE NEWSWIRE) -- The "T-Cell Therapy Market by Type of Therapy, Target Indication, Target Antigen, Company Size, Geographical Regions, Leading Players and Sales Forecast of...
Registration Now Open: Extracellular Vesicles (EVs) & Lipid Nanoparticles (LNPs) Conference 2025 (Miami, FLORIDA, United States - May 15-16, 2025)
March 25, 2025 05:30 ET
|
Research and Markets
Dublin, March 25, 2025 (GLOBE NEWSWIRE) -- The "Extracellular Vesicles (EVs) & Lipid Nanoparticles (LNPs) 2025" conference has been added to ResearchAndMarkets.com's offering. The...
Longeveron® Announces Positive Type B Meeting with U.S. FDA Regarding Pathway to BLA for Laromestrocel (Lomecel-BTM) in Alzheimer’s Disease
March 20, 2025 09:00 ET
|
Longeveron
Longeveron reaches alignment with US FDA on single, pivotal clinical trial to BLA submission for cell therapy for treatment of Alzheimer's disease.
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
March 20, 2025 07:00 ET
|
Wugen
Wugen Announces Dosing of First Patients in Pivotal Trial of Off-the-Shelf, Allogeneic, CD7-Targeted CAR-T Cell Therapy WU-CART-007
Therapeutic Antibodies, Biosimilars & RNA Therapy Sales Report - Top-Selling Biologic Drugs & Market Trends for 2024
March 19, 2025 08:21 ET
|
Research and Markets
Dublin, March 19, 2025 (GLOBE NEWSWIRE) -- The "2024 Sales of Therapeutic Antibodies, Proteins, Biosimilars, Gene & Cell Therapy and Therapeutic RNA" report has been added to ...
Leading Academic and Manufacturing Organizations Join Ori Biotech’s Preferred Partner Network to Accelerate the Commercialization of Cell and Gene Therapies
March 18, 2025 09:00 ET
|
Oribiotech Ltd
Oribiotech Ltd. (Ori), announced the launch of its Preferred Partner Network (PPN), bringing together top AMCs and CDMOs.
Coeptis Therapeutics Secures Worldwide Development and Commercialization Rights to Next-Generation GEAR™ Cell Therapy Platform Strengthening its High-Impact Precision Immuno-Oncology Pipeline
March 11, 2025 08:34 ET
|
Coeptis Therapeutics
• COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for broad range of cancers and other therapeutic...
Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight
March 05, 2025 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, March 05, 2025 (GLOBE NEWSWIRE) -- Global Cell and Gene Therapy Manufacturing Market to Reach ~USD 10 Billion by 2032 | DelveInsight The growing incidence of genetic disorders and...
KSQ Therapeutics Appoints Kristen Hege, M.D., to its Board of Directors
March 05, 2025 07:00 ET
|
KSQ
KSQ Therapeutics Appoints Kristen Hege, M.D., to its Board of Directors